Kings Path Partners’s Abbott ABT Stock Holding History

Kings Path Partners’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,037	Closed	-$909K	–	258
2024 Q4	$909K	Hold	8,037	–	–	0.39%	66
2024 Q3	$916K	Hold	8,037	–	–	0.38%	66
2024 Q2	$835K	Buy	+8,037	New	+$852K	0.39%	66

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Kings Path Partners's ABT Position: Q1 2025 in Review

Kings Path Partners sold out of Abbott (ABT) in Q1 2025, closing a stake of 8,037 shares — an estimated $909K sold.

Kings Path Partners first reported a position in ABT in Q2 2024 and held it in 3 quarters. The position peaked at $916K in Q3 2024. 3,168 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

Kings Path Partners reported no remaining Abbott position as of Q1 2025 after selling out during the quarter.
Kings Path Partners sold 8,037 Abbott shares in Q1 2025, an estimated $909K.
Kings Path Partners first reported a position in Abbott in Q2 2024 and held it in 3 quarters.
Kings Path Partners's Abbott position peaked at $916K in Q3 2024.
3,168 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on Kings Path Partners's 13F filing for Q1 2025, filed 4 Apr 2025.